Sunstone Capital

Get funding

Sunstone Life Science Ventures is an independent European venture capital investment firm.

Use: Go2Market;
Date closing: -
Amount: -
Industry focus: Health;
Total budget: 92M €
Entity type: Venture Capital
Vertical focus: therapeutics, health,
Website: www.sunstone.eu

Status:
Open
Funding type: Equity investment;
Geographic focus: Europe; Nordics;
Public/Private: Private
Stage focus: Seed; Series A;
Applicant target: Startup;

Add a Review Send question

Overview

Sunstone Life Science Ventures invests in early-stage life science companies developing novel therapeutics for humans. They are a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use

Their portfolio is managed through a series of funds. Fund IV, focusing solely on therapeutics, is actively pursuing new investment opportunities.

Their geographical scope is Europe including UK with particular emphasis on the European life science hubs.

Sunstone Life Science Ventures Fund IV was established in 2019. The total committed capital is EUR 92 million. The investment strategy is focused entirely on therapeutics. The fund is currently building the portfolio and is actively pursuing new investment opportunities.

Portfolio: Arcoma, OxThera, Galecto, IoBiotech.

Last updated on 2023-04-27 15:00